---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-003762"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-26T23:57:39.233802+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics terminates $200M ATM equity facility with Cowen, effective Feb 14, 2025

## Summary
- Terminated Sales Agreement with Cowen and Company effective Feb 14, 2025.
- Agreement allowed sale of up to $200M in common stock via ATM program.
- Company provided notice on Feb 4, 2025; no reason disclosed for termination.

## SEC filing metadata
- accession: 0001140361-25-003762
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/0001140361-25-003762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/ef20043253_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-003762
- JSON: https://secwatch.observer/filing/0001140361-25-003762.json
- Plain text: https://secwatch.observer/filing/0001140361-25-003762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.